Durable Hematological and Major Cytogenetic Response in a Patient with Isolated 20q Deletion Myelodysplastic Syndrome Treated with Lenalidomide

Table 1

Flow cytometry after 3 weeks of lenalidomide treatment.

Flow cytometry differential (% of total cells)
Lymphocytes	44
B-cells	4
Kappa	1
Lambda	<1
Kappa : Lambda ratio	2
T-cells	39
CD4	28
CD8	11
CD4 : CD8 ratio	2.7
CD3+CD56+	2
Natural killer cells	1
Monocytes	5
Granulocytes	42
CD34-positive blasts	3
Plasma cells	<1
Viability	97